---
document_datetime: 2023-09-21 19:54:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/beovu-epar-all-authorised-presentations_en.pdf
document_name: beovu-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8113638
conversion_datetime: 2025-12-19 06:52:24.496892
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form    | Route of administration   | Immediate packaging        | Content (concentration)   | Pack size            |
|------------------|-------------------|------------|------------------------|---------------------------|----------------------------|---------------------------|----------------------|
| EU/1/19/1417/001 | Beovu             | 120 mg/ml  | Solution for injection | Intravitreal use          | pre-filled syringe (glass) | 0.165 ml                  | 1 pre-filled syringe |
| EU/1/19/1417/002 | Beovu             | 120 mg/ml  | Solution for injection | Intravitreal use          | vial (glass)               | 0.230 ml                  | 1 vial + 1 needle    |